The basics of bacteriuria: Strategies of microbes for persistence in urine

Frontiers in Cellular and Infection Microbiology

Volumn 6, Issue FEB, 2016, Pages

  Ipe, Deepak S ^a   Horton, Ella ^a   Ulett, Glen C ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Artificial urine; Asymptomatic bacteriuria; Bacteriuria; Synthetic human urine; Urinalysis; Urinary tract infection; Urine; Uropathogen

Indexed keywords

2 OXOGLUTARIC ACID; ARGININE; ASPARTIC ACID; BETAINE; CYSTEINE SYNTHASE; GLUTAMIC ACID; GLYCEROL; MALIC ACID; N ACETYLGLUCOSAMINE; OXALOACETIC ACID; SIDEROPHORE; SUCROSE; TOLL LIKE RECEPTOR 4; UREA; GUANINE; MALIC ACID DERIVATIVE; SERINE;

ANTIBIOTIC RESISTANCE; BACTERIAL SURVIVAL; BACTERIURIA; BLADDER MUCOSA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HOST; HUMAN; IMMUNOSURVEILLANCE; IN VITRO STUDY; IRON TRANSPORT; MICROBIAL GROWTH; MICROBIAL METABOLISM; MODEL; MUTAGENESIS; NONHUMAN; OSMOADAPTION; PHENOTYPE; SHORT SURVEY; SYNTHETIC HUMAN URINE; TRANSPOSON; URINE; VIRULENCE; ADAPTATION; ASYMPTOMATIC INFECTION; BIOSYNTHESIS; BLADDER; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ASYMPTOMATIC INFECTIONS; BACTERIURIA; ESCHERICHIA COLI; GUANINE; HUMANS; MALATES; SERINE; URINARY BLADDER;

EID: 85006220641     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2016.00014     Document Type: Short Survey

References (170)

1. Alteri, C. J., and Mobley, H. L. (2007). Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect. Immun. 75, 2679-2688. doi: 10.1128/IAI.00076-06
2. Alteri, C. J., Smith, S. N., and Mobley, H. L. (2009). Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog. 5:e1000448. doi: 10.1371/journal.ppat.1000448
3. Andersson, P., Engberg, I., Lidin-Janson, G., Lincoln, K., Hull, R., Hull, S., et al. (1991). Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect. Immun. 59, 2915-2921.
4. Ariathianto, Y. (2011). Asymptomatic bacteriuria-prevalence in the elderly population. Aust. Fam. Physician 40, 805-809.
5. Arthur, M., Johnson, C. E., Rubin, R. H., Arbeit, R. D., Campanelli, C., Kim, C., et al. (1989). Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect. Immun. 57, 303-313.
6. Aubron, C., Glodt, J., Matar, C., Huet, O., Borderie, D., Dobrindt, U., et al. (2012). Variation in endogenous oxidative stress in Escherichia coli natural isolates during growth in urine. BMC Microbiol. 12:120. doi: 10.1186/1471-2180-12-120
7. Aurora, A. L., Rao, A. S., and Srimathi, V. (1980). Effects of constituents of artificial urine on spontaneous precipitation of calcium oxalate monohydrate (whewellite). Ind. J. Med. Res. 72, 273-283.
8. Azevedo, A. S., Almeida, C., Melo, L. F., and Azevedo, N. F. (2014). Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms. Biofouling 30, 893-902. doi: 10.1080/08927014.2014.944173
9. Barker, L. M., Pallante, S. L., Eisenberg, H., Joule, J. A., Becker, G. L., and Howard, J. E. (1974). Simple synthetic and natural urines have equivalent anticalcifying properties. Invest. Urol. 12, 79-81.
10. Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., and Pirkle, J. L. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113, 192-200. doi: 10.1289/ehp.7337
11. Barron, A., May, G., Bremer, E., and Villarejo, M. (1986). Regulation of envelope protein composition during adaptation to osmotic stress in Escherichia coli. J. Bacteriol. 167, 433-438.
12. Bates, J. M., Raffi, H. M., Prasadan, K., Mascarenhas, R., Laszik, Z., Maeda, N., et al. (2004). Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65, 791-797. doi: 10.1111/j.1523-1755.2004.00452.x
13. Berger, A., Dohnt, K., Tielen, P., Jahn, D., Becker, J., and Wittmann, C. (2014). Robustness and plasticity of metabolic pathway flux among uropathogenic isolates of Pseudomonas aeruginosa. PLoS ONE 9:e88368. doi: 10.1371/journal.pone.0088368
14. Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., et al. (2013). The human urine metabolome. PLoS ONE 8:e73076. doi: 10.1371/journal.pone.0073076
15. Brooks, T., and Keevil, C. W. (1997). A simple artificial urine for the growth of urinary pathogens. Lett. Appl. Microbiol. 24, 203-206. doi: 10.1046/j.1472-765X.1997.00378.x
16. Brown, P., Ackermann, D., and Finlayson, B. (1989). Calcium-Oxalate Dihydrate (Weddellite) Precipitation. J. Cryst. Growth 98, 285-292. doi: 10.1016/0022-0248(89)90143-7
17. Burns, J. R., and Finlayson, B. (1980). A proposal for a standard reference artificial urine in in vitro urolithiasis experiments. Invest. Urol. 18, 167-169.
18. Carey, A. J., Sullivan, M. J., Duell, B. L., Crossman, D. K., Chattopadhyay, D., Brooks, A. J., et al. (2016). Uropathogenic Escherichia coli engages CD14-dependent signaling to enable bladder-macrophage-dependent control of acute urinary tract infection. J. Infect. Dis. 213, 659-668. doi: 10.1093/infdis/jiv424
19. Carlsson, S., Wiklund, N. P., Engstrand, L., Weitzberg, E., and Lundberg, J. O. (2001). Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide 5, 580-586. doi: 10.1006/niox.2001.0371
20. Chambers, S. T., and Lever, M. (1996). Betaines and urinary tract infections. Nephron 74, 1-10. doi: 10.1159/000189274
21. Chaturvedi, K. S., Hung, C. S., Crowley, J. R., Stapleton, A. E., and Henderson, J. P. (2012). The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat. Chem. Biol. 8, 731-736. doi: 10.1038/nchembio.1020
22. Christmas, K. G., Gower, L. B., Khan, S. R., and El-Shall, H. (2002). Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species. J. Colloid Interface Sci. 256, 168-174. doi: 10.1006/jcis.2002.8283
23. Chromek, M., Slamová, Z., Bergman, P., Kovács, L., Podracká, L., Ehrén, I., et al. (2006). The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641. doi: 10.1038/nm1407
24. Chutipongtanate, S., and Thongboonkerd, V. (2010). Systematic comparisons of artificial urine formulas for in vitro cellular study. Anal. Biochem. 402, 110-112. doi: 10.1016/j.ab.2010.03.031
25. Clarke, M., Pead, L., and Maskell, R. (1985). Urinary infection in adult men: a laboratory perspective. Br. J. Urol. 57, 222-226. doi: 10.1111/j.1464-410X.1985.tb06429.x
26. Cosloy, S. D., and McFall, E. (1973). Metabolism of D-serine in Escherichia coli K-12: mechanism of growth inhibition. J. Bacteriol. 114, 685-694.
27. Dalal, S., Nicolle, L., Marrs, C. F., Zhang, L., Harding, G., and Foxman, B. (2009). Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clin. Infect. Dis. 49, 491-497. doi: 10.1086/600883
28. Dalhoff, A., Stubbings, W., and Schubert, S. (2011). Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine. Antimicrob. Agents Chemother. 55, 1814-1818. doi: 10.1128/AAC.00886-10
29. Darouiche, R. O., Mansouri, M. D., Gawande, P. V., and Madhyastha, S. (2008). Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. J. Antimicrob. Chemother. 61, 651-657. doi: 10.1093/jac/dkn006
30. Davis, C. P., Arnett, D., and Warren, M. M. (1982). Iontophoretic killing of Escherichia coli in static fluid and in a model catheter system. J. Clin. Microbiol. 15, 891-894.
31. Davis, C. P., Wagle, N., Anderson, M. D., and Warren, M. M. (1991). Bacterial and fungal killing by iontophoresis with long-lived electrodes. Antimicrob. Agents Chemother. 35, 2131-2134. doi: 10.1128/AAC.35.10.2131
32. Davis, C. P., Weinberg, S., Anderson, M. D., Rao, G. M., and Warren, M. M. (1989). Effects of microamperage, medium, and bacterial concentration on iontophoretic killing of bacteria in fluid. Antimicrob. Agents Chemother. 33, 442-447. doi: 10.1128/AAC.33.4.442
33. Decramer, S., Gonzalez de Peredo, A., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J. L., et al. (2008). Urine in clinical proteomics. Mol. Cell. Proteomics 7, 1850-1862. doi: 10.1074/mcp.R800001-MCP200
34. Deutch, C. E., Arballo, M. E., Cooks, L. N., Gomes, J. M., Williams, T. M., Aboul-Fadl, T., et al. (2006). Susceptibility of Escherichia coli to L-selenaproline and other L-proline analogues in laboratory culture media and normal human urine. Lett. Appl. Microbiol. 43, 392-398. doi: 10.1111/j.1472-765X.2006.01979.x
35. Dinnbier, U., Limpinsel, E., Schmid, R., and Bakker, E. P. (1988). Transient accumulation of potassium glutamate and its replacement by trehalose during adaptation of growing cells of Escherichia coli K-12 to elevated sodium chloride concentrations. Arch. Microbiol. 150, 348-357. doi: 10.1007/BF00408306
36. Domergue, R., Castaño, I., De Las Peñas, A., Zupancic, M., Lockatell, V., Hebel, J. R., et al. (2005). Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308, 866-870. doi: 10.1126/science.1108640
37. Doremus, R. H., Teich, S., and Silvis, P. X. (1978). Crystallization of calcium oxalate from synthetic urine. Invest. Urol. 15, 469-472.
38. Duell, B. L., Carey, A. J., Tan, C. K., Cui, X., Webb, R. I., Totsika, M., et al. (2012). Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J. Immunol. 188, 781-792. doi: 10.4049/jimmunol.1101231
39. Fischer, H., Lutay, N., Ragnarsdóttir, B., Yadav, M., Jönsson, K., Urbano, A., et al. (2010). Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog. 6:e1001109. doi: 10.1371/journal.ppat.1001109
40. Frendéus, B., Wachtler, C., Hedlund, M., Fischer, H., Samuelsson, P., Svensson, M., et al. (2001). Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol. Microbiol. 40, 37-51. doi: 10.1046/j.1365-2958.2001.02361.x
41. Garcia, E. C., Brumbaugh, A. R., and Mobley, H. L. (2011). Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79, 1225-1235. doi: 10.1128/IAI.01222-10
42. Gardner, G. L., and Doremus, R. H. (1978). Crystal growth inhibitors in human urine. Effect on calcium oxalate kinetics. Invest. Urol. 15, 478-485.
43. Gonzalez-Chavez, S. A., Arevalo-Gallegos, S., and Rascon-Cruz, Q. (2009). Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 33, 301, e301-e308. doi: 10.1016/j.ijantimicag.2008.07.020
44. Gordon, D. M., and Riley, M. A. (1992). A theoretical and experimental analysis of bacterial growth in the bladder. Mol. Microbiol. 6, 555-562. doi: 10.1111/j.1365-2958.1992.tb01500.x
45. Grases, F., and Llobera, A. (1998). Experimental model to study sedimentary kidney stones. Micron 29, 105-111. doi: 10.1016/S0968-4328(98)00006-7
46. Greene, S. E., Hibbing, M. E., Janetka, J., Chen, S. L., and Hultgren, S. J. (2015). Human urine decreases function and expression of Type 1 pili in uropathogenic Escherichia coli. MBio 6:e00820. doi: 10.1128/mBio.00820-15
47. Griffith, D. P., Musher, D. M., and Itin, C. (1976). Urease. The primary cause of infection-induced urinary stones. Invest. Urol. 13, 346-350.
48. Grönberg-Hernández, J., Sundén, F., Connolly, J., Svanborg, C., and Wullt, B. (2011). Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS ONE 6:e28289. doi: 10.1371/journal.pone.0028289
49. Guo, K., and Li, L. (2009). Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal. Chem. 81, 3919-3932. doi: 10.1021/ac900166a
50. Gutierrez, C., Ardourel, M., Bremer, E., Middendorf, A., Boos, W., and Ehmann, U. (1989). Analysis and DNA sequence of the osmoregulated treA gene encoding the periplasmic trehalase of Escherichia coli K12. Mol. Gen. Genet. 217, 347-354. doi: 10.1007/BF02464903
51. Hagan, E. C., and Mobley, H. L. (2009). Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 71, 79-91. doi: 10.1111/j.1365-2958.2008.06509.x
52. Hand, W. L., Smith, J. W., and Sanford, J. P. (1971). The antibacterial effect of normal and infected urinary bladder. J. Lab. Clin. Med. 77, 605-615.
53. Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L., and Hultgren, S. J. (2010). Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6:e1001042. doi: 10.1371/journal.ppat.1001042
54. Hannan, T. J., Totsika, M., Mansfield, K. J., Moore, K. H., Schembri, M. A., and Hultgren, S. J. (2012). Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol. Rev. 36, 616-648. doi: 10.1111/j.1574-6976.2012.00339.x
55. Håversen, L. A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L. A., and Mattsby-Baltzer, I. (2000). Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun. 68, 5816-5823. doi: 10.1128/IAI.68.10.5816-5823.2000
56. Hood, M. I., and Skaar, E. P. (2012). Nutritional immunity: transition metals at the pathogen-host interface. Nat. Rev. Microbiol. 10, 525-537. doi: 10.1038/nrmicro2836
57. Hooton, T. M., Scholes, D., Stapleton, A. E., Roberts, P. L., Winter, C., Gupta, K., et al. (2000). A prospective study of asymptomatic bacteriuria in sexually active young women. N. Engl. J. Med. 343, 992-997. doi: 10.1056/NEJM200010053431402
58. Hryckowian, A. J., Baisa, G. A., Schwartz, K. J., and Welch, R. A. (2015). dsdA does not affect colonization of the murine urinary tract by Escherichia coli CFT073. PLoS ONE 10:e0138121. doi: 10.1371/journal.pone.0138121
59. Huang, Y., Nishikawa, T., Satoh, K., Iwata, T., Fukushima, T., Santa, T., et al. (1998). Urinary excretion of D-serine in human: comparison of different ages and species. Biol. Pharm. Bull. 21, 156-162. doi: 10.1248/bpb.21.156
60. Hull, R., Rudy, D., Donovan, W., Svanborg, C., Wieser, I., Stewart, C., et al. (2000). Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J. Urol. 163, 872-877. doi: 10.1016/S0022-5347(05)67823-8
61. Ipe, D. S., Ben Zakour, N. L., Sullivan, M. J., Beatson, S. A., Ulett, K. B., Benjamin, W. H., et al. (2016). Discovery and characterization of human urine utilization by asymptomatic bacteriuria streptococcus agalactiae. Infect. Immun. 84, 307-319. doi: 10.1128/IAI.00938-15
62. Ipe, D. S., Sundac, L., Benjamin, W. H. Jr., Moore, K. H., and Ulett, G. C. (2013). Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiol. Lett. 346, 1-10. doi: 10.1111/1574-6968.12204
63. Isaacson, L. C. (1969). Urinary composition in calcific nephrolithiasis. Invest. Urol. 6, 356-363.
64. Jain, N., Kohli, R., Cook, E., Gialanella, P., Chang, T., and Fries, B. C. (2007). Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl. Environ. Microbiol. 73, 1697-1703. doi: 10.1128/AEM.02439-06
65. Järvisalo, J., Olkinuora, M., Kiilunen, M., Kivistö, H., Ristola, P., Tossavainen, A., et al. (1992). Urinary and blood manganese in occupationally nonexposed populations and in manual metal arc welders of mild steel. Int. Arch. Occup. Environ. Health 63, 495-501. doi: 10.1007/BF00572116
66. Johnson, J. R., Clabots, C., and Rosen, H. (2006). Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect. Immun. 74, 461-468. doi: 10.1128/IAI.74.1.461-468.2006
67. King, J. E., Aal Owaif, H. A., Jia, J., and Roberts, I. S. (2015). Phenotypic heterogeneity in expression of the K1 polysaccharide capsule of uropathogenic Escherichia coli and downregulation of the capsule genes during growth in urine. Infect. Immun. 83, 2605-2613. doi: 10.1128/IAI.00188-15
68. Klemm, P., Hancock, V., and Schembri, M. A. (2007). Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect. Immun. 75, 3688-3695. doi: 10.1128/IAI.01730-06
69. Klemm, P., Roos, V., Ulett, G. C., Svanborg, C., and Schembri, M. A. (2006). Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect. Immun. 74, 781-785. doi: 10.1128/IAI.74.1.781-785.2006
70. Kline, K. A., Schwartz, D. J., Gilbert, N. M., Hultgren, S. J., and Lewis, A. L. (2012). Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect. Immun. 80, 4186-4194. doi: 10.1128/IAI.00684-12
71. Kucheria, R., Dasgupta, P., Sacks, S. H., Khan, M. S., and Sheerin, N. S. (2005). Urinary tract infections: new insights into a common problem. Postgrad. Med. J. 81, 83-86. doi: 10.1136/pgmj.2004.023036
72. Kunin, C. M., Hua, T. H., and Bakaletz, L. O. (1995). Effect of salicylate on expression of flagella by Escherichia coli and Proteus, Providencia, and Pseudomonas spp. Infect. Immun. 63, 1796-1799.
73. Kunin, C. M., Hua, T. H., Guerrant, R. L., and Bakaletz, L. O. (1994). Effect of salicylate, bismuth, osmolytes, and tetracycline resistance on expression of fimbriae by Escherichia coli. Infect. Immun. 62, 2178-2186.
74. Kunin, C. M., Hua, T. H., Van Arsdale White, L., and Villarejo, M. (1992). Growth of Escherichia coli in human urine: role of salt tolerance and accumulation of glycine betaine. J. Infect. Dis. 166, 1311-1315. doi: 10.1093/infdis/166.6.1311
75. Laimins, L. A., Rhoads, D. B., Altendorf, K., and Epstein, W. (1978). Identification of the structural proteins of an ATP-driven potassium transport system in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 75, 3216-3219. doi: 10.1073/pnas.75.7.3216
76. Landete, J. M., García-Haro, L., Blasco, A., Manzanares, P., Berbegal, C., Monedero, V., et al. (2010). Requirement of the Lactobacillus casei MaeKR two-component system for L-malic acid utilization via a malic enzyme pathway. Appl. Environ. Microbiol. 76, 84-95. doi: 10.1128/AEM.02145-09
77. La Rosa, S. L., Diep, D. B., Nes, I. F., and Brede, D. A. (2012). Construction and application of a luxABCDE reporter system for real-time monitoring of Enterococcus faecalis gene expression and growth. Appl. Environ. Microbiol. 78, 7003-7011. doi: 10.1128/AEM.02018-12
78. Lee, S. C., Hutchinson, J. M., Inn, K. G., and Thein, M. (1995). An intercomparison study of 237Np determination in artificial urine samples. Health Phys. 68, 350-358. doi: 10.1097/00004032-199503000-00007
79. Lehman, S. M., and Donlan, R. M. (2015). Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrob. Agents Chemother. 59, 1127-1137. doi: 10.1128/AAC.03786-14
80. Leonhardt, K. O., and Landes, R. R. (1963). Oxygen tension of the urine and renal structures. Preliminary report of clinical findings. N. Engl. J. Med. 269, 115-121. doi: 10.1056/NEJM196307182690301
81. Lomberg, H., Hanson, L. A., Jacobsson, B., Jodal, U., Leffler, H., and Edén, C. S. (1983). Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N. Engl. J. Med. 308, 1189-1192. doi: 10.1056/NEJM198305193082003
82. Low, Y. L., Jakubovics, N. S., Flatman, J. C., Jenkinson, H. F., and Smith, A. W. (2003). Manganese-dependent regulation of the endocarditis-associated virulence factor EfaA of Enterococcus faecalis. J. Med. Microbiol. 52, 113-119. doi: 10.1099/jmm.0.05039-0
83. Mabbett, A. N., Ulett, G. C., Watts, R. E., Tree, J. J., Totsika, M., Ong, C. L., et al. (2009). Virulence properties of asymptomatic bacteriuria Escherichia coli. Int. J. Med. Microbiol. 299, 53-63. doi: 10.1016/j.ijmm.2008.06.003
84. Mansouri, M. D., and Darouiche, R. O. (2008). In-vitro activity and in-vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens. Clin. Microbiol. Infect. 14, 190-192. doi: 10.1111/j.1469-0691.2007.01894.x
85. Martino, P. D., Fursy, R., Bret, L., Sundararaju, B., and Phillips, R. S. (2003). Indole can act as an extracellular signal to regulate biofilm formation of Escherichia coli and other indole-producing bacteria. Can. J. Microbiol. 49, 443-449. doi: 10.1139/w03-056
86. Mayrovitz, H. N., and Sims, N. (2001). Biophysical effects of water and synthetic urine on skin. Adv. Skin Wound Care 14, 302-308. doi: 10.1097/00129334-200111000-00013
87. Meury, J., Robin, A., and Monnier-Champeix, P. (1985). Turgor-controlled K+ fluxes and their pathways in Escherichia coli. Eur. J. Biochem. 151, 613-619. doi: 10.1111/j.1432-1033.1985.tb09148.x
88. Miller, J. D., Randolph, A. D., and Drach, G. W. (1977). Observations upon calcium oxalate crystallization kinetics in simulated urine. J. Urol. 117, 342-345.
89. Minuth, J. N., Musher, D. M., and Thorsteinsson, S. B. (1976). Inhibition of the antibacterial activity of gentamicin by urine. J. Infect. Dis. 133, 14-21. doi: 10.1093/infdis/133.1.14
90. Negri, M., Silva, S., Breda, D., Henriques, M., Azeredo, J., and Oliveira, R. (2012). Candida tropicalis biofilms: effect on urinary epithelial cells. Microb. Pathog. 53, 95-99. doi: 10.1016/j.micpath.2012.05.006
91. Negri, M., Silva, S., Capoci, I. R., Azeredo, J., and Henriques, M. (2015). Candida tropicalis biofilms: biomass, metabolic activity and secreted aspartyl proteinase production. Mycopathologia. doi: 10.1007/s11046-015-9964-4. [Epub ahead of print].
92. Negri, M., Silva, S., Henriques, M., Azeredo, J., Svidzinski, T., and Oliveira, R. (2011). Candida tropicalis biofilms: artificial urine, urinary catheters and flow model. Medical Mycology 49, 739-747. doi: 10.3109/13693786.2011.560619
93. Nickel, J. C., Ruseska, I., Wright, J. B., and Costerton, J. W. (1985). Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27, 619-624. doi: 10.1128/AAC.27.4.619
94. Nicolle, L. E. (1997). Asymptomatic bacteriuria in the elderly. Infect. Dis. Clin. North Am. 11, 647-662. doi: 10.1016/S0891-5520(05)70378-0
95. Nicolle, L. E. (1999). Urinary infections in the elderly: symptomatic of asymptomatic? Int. J. Antimicrob. Agents 11, 265-268.
96. Nicolle, L. E. (2014). Asymptomatic bacteriuria. Curr. Opin. Infect. Dis. 27, 90-96. doi: 10.1097/QCO.0000000000000019
97. Nicolle, L. E., Bradley, S., Colgan, R., Rice, J. C., Schaeffer, A., and Hooton, T. M. (2005). Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin. Infect. Dis. 40, 643-654. doi: 10.1086/427507
98. Nielubowicz, G. R., and Mobley, H. L. (2010). Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7, 430-441. doi: 10.1038/nrurol.2010.101
99. O'grady, F., and Cattell, W. R. (1966a). Kinetics of urinary tract infection. I. Upper urinary tract. Br. J. Urol. 38, 149-155.
100. O'grady, F., and Cattell, W. R. (1966b). Kinetics of urinary tract infection. II. The bladder. Br. J. Urol. 38, 156-162.
101. O'grady, F., and Pennington, J. H. (1966). Bacterial growth in an in vitro system simulating conditions in the urinary bladder. Br. J. Exp. Pathol. 47, 152-157.
102. Ong, C. L., Beatson, S. A., McEwan, A. G., and Schembri, M. A. (2009). Conjugative plasmid transfer and adhesion dynamics in an Escherichia coli biofilm. Appl. Environ. Microbiol. 75, 6783-6791. doi: 10.1128/AEM.00974-09
103. Ong, C. L., Beatson, S. A., Totsika, M., Forestier, C., McEwan, A. G., and Schembri, M. A. (2010). Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiol. 10:183. doi: 10.1186/1471-2180-10-183
104. Opalko, F. J., Adair, J. H., and Khan, S. R. (1997). Heterogeneous nucleation of calcium oxalate trihydrate in artificial urine by constant composition. J. Cryst. Growth 181, 410-417. doi: 10.1016/S0022-0248(97)00222-4
105. Pätzold, R., Schieber, A., and Brückner, H. (2005). Gas chromatographic quantification of free D-amino acids in higher vertebrates. Biomed. Chromatogr. 19, 466-473. doi: 10.1002/bmc.515
106. Phuengkham, H., and Nasongkla, N. (2015). Development of antibacterial coating on silicone surface via chlorhexidine-loaded nanospheres. J. Mater. Sci. Mater. Med. 26:78. doi: 10.1007/s10856-015-5418-2
107. Putnam, D. F., Company-West, M. D. A., Center, L. R., Aeronautics, U. S. N., and Administration, S. (1971). Composition and Concentrative Properties of Human Urine. Washington, DC: National Aeronautics and Space Administration.
108. Raffi, H. S., Bates, J. M. Jr., Laszik, Z., and Kumar, S. (2005). Tamm-Horsfall protein acts as a general host-defense factor against bacterial cystitis. Am. J. Nephrol. 25, 570-578. doi: 10.1159/000088990
109. Ragnarsdóttir, B., and Svanborg, C. (2012). Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatric Nephrol. 27, 2017-2029. doi: 10.1007/s00467-011-2089-1
110. Rane, H. S., Bernardo, S. M., Howell, A. B., and Lee, S. A. (2014). Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm-and adherence-specific mechanisms. J. Antimicrob. Chemother. 69, 428-436. doi: 10.1093/jac/dkt398
111. Robertson, W. G., Peacock, M., and Nordin, B. E. (1968). Activity products in stone-forming and non-stone-forming urine. Clin. Sci. 34, 579-594.
112. Robertson, W. G., and Scurr, D. S. (1986). Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine. J. Urol. 135, 1322-1326.
113. Robertson, W. G., Scurr, D. S., and Bridge, C. M. (1981). Factors influencing the crystallization of calcium-oxalate in urine-critique. J. Cryst. Growth 53, 182-194. doi: 10.1016/0022-0248(81)90064-6
114. Robinson, A. V., Fisher, D. R., and Hadley, R. T. (1984). Technical Evaluation of Draft ANSI Standard N13.30, Performance Criteria for Radioassay. Richland, WA: Pacific Northwest Laboratory.
115. Rodgers, A. L., and Wandt, M. A. (1991). Influence of ageing, pH and various additives on crystal formation in artificial urine. Scanning Microsc. 5, 697-705. discussion: 705-696.
116. Roesch, P. L., Redford, P., Batchelet, S., Moritz, R. L., Pellett, S., Haugen, B. J., et al. (2003). Uropathogenic Escherichia coli use D-serine deaminase to modulate infection of the murine urinary tract. Mol. Microbiol. 49, 54-67. doi: 10.1046/j.1365-2958.2003.03543.x
117. Ronald, A., and Ludwig, E. (2001). Urinary tract infections in adults with diabetes. Int. J. Antimicrob. Agents 17, 287-292. doi: 10.1016/S0924-8579(00)00356-3
118. Roos, V., Nielsen, E. M., and Klemm, P. (2006a). Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol. Lett. 262, 22-30. doi: 10.1111/j.1574-6968.2006.00355.x
119. Roos, V., Ulett, G. C., Schembri, M. A., and Klemm, P. (2006b). The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect. Immun. 74, 615-624. doi: 10.1128/IAI.74.1.615-624.2006
120. Rose, M. B. (1975). Renal stone formation. The inhibitory effect of urine on calcium oxalate precipitation. Invest. Urol. 12, 428-433.
121. Rubin, R. H., Shapiro, E. D., Andriole, V. T., Davis, R. J., and Stamm, W. E. (1992). Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 15(Suppl. 1), S216-S227. doi: 10.1093/clind/15.supplement_1.s216
122. Rudick, C. N., Billips, B. K., Pavlov, V. I., Yaggie, R. E., Schaeffer, A. J., and Klumpp, D. J. (2010). Host-pathogen interactions mediating pain of urinary tract infection. J. Infect. Dis. 201, 1240-1249. doi: 10.1086/651275
123. Russo, T. A., Jodush, S. T., Brown, J. J., and Johnson, J. R. (1996). Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol. Microbiol. 22, 217-229. doi: 10.1046/j.1365-2958.1996.00096.x
124. Russo, T. A., Olson, R., Macdonald, U., Beanan, J., and Davidson, B. A. (2015). Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect. Immun. 83, 3325-3333. doi: 10.1128/IAI.00430-15
125. Ryall, R. L., Harnett, R. M., Hibberd, C. M., Mazzachi, B. C., Mazzachi, R. D., and Marshall, V. R. (1987). Urinary risk factors in calcium oxalate stone disease: comparison of men and women. Br. J. Urol. 60, 480-488. doi: 10.1111/j.1464-410X.1987.tb05025.x
126. Säemann, M. D., Weichhart, T., Hörl, W. H., and Zlabinger, G. J. (2005). Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur. J. Clin. Invest. 35, 227-235. doi: 10.1111/j.1365-2362.2005.01483.x
127. Sakinç, T., Michalski, N., Kleine, B., and Gatermann, S. G. (2009). The uropathogenic species Staphylococcus saprophyticus tolerates a high concentration of D-serine. FEMS Microbiol. Lett. 299, 60-64. doi: 10.1111/j.1574-6968.2009.01731.x
128. Sako, S., Kariyama, R., Mitsuhata, R., Yamamoto, M., Wada, K., Ishii, A., et al. (2014). Molecular epidemiology and clinical implications of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from urine. Acta Med. Okayama 68, 89-99.
129. Salvador, E., Wagenlehner, F., Kohler, C. D., Mellmann, A., Hacker, J., Svanborg, C., et al. (2012). Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect. Immun. 80, 668-678. doi: 10.1128/IAI.06191-11
130. Samaranayake, Y. H., Bandara, H. M., Cheung, B. P., Yau, J. Y., Yeung, S. K., and Samaranayake, L. P. (2014). Enteric Gram-negative bacilli suppress Candida biofilms on Foley urinary catheters. APMIS 122, 47-58. doi: 10.1111/apm.12098
131. Sarada, B., and Satyanarayana, U. (1991). Urinary composition in men and women and the risk of urolithiasis. Clin. Biochem. 24, 487-490. doi: 10.1016/S0009-9120(05)80007-4
132. Schneeberger, C., Geerlings, S. E., Middleton, P., and Crowther, C. A. (2012). Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst. Rev. 11:CD009279. doi: 10.1002/14651858.CD009279.pub2
133. Schneeberger, C., Kazemier, B. M., and Geerlings, S. E. (2014). Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr. Opin. Infect. Dis. 27, 108-114. doi: 10.1097/QCO.0000000000000028
134. Shaykhutdinov, R. A., Macinnis, G. D., Dowlatabadi, R., Weljie, A. M., and Vogel, H. J. (2009). Quantitative analysis of metabolite concentrations in human urine samples using 13C{1H} NMR spectroscopy. Metabolomics 5, 307-317. doi: 10.1007/s11306-009-0155-5
135. Sheewin, N. S. (2011). Urinary tract infection. Medicine 39, 384-389. doi: 10.1016/j.mpmed.2011.04.003
136. Shepard, B. D., and Gilmore, M. S. (2002). Differential expression of virulence-related genes in Enterococcus faecalis in response to biological cues in serum and urine. Infect. Immun. 70, 4344-4352. doi: 10.1128/IAI.70.8.4344-4352.2002
137. Shields-Cutler, R. R., Crowley, J. R., Hung, C. S., Stapleton, A. E., Aldrich, C. C., Marschall, J., et al. (2015). Human urinary composition controls antibacterial activity of siderocalin. J. Biol. Chem. 290, 15949-15960. doi: 10.1074/jbc.M115.645812
138. Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D., and Azeredo, J. (2010). Silicone colonization by non-Candida albicans Candida species in the presence of urine. J. Med. Microbiol. 59, 747-754. doi: 10.1099/jmm.0.017517-0
139. Snyder, J. A., Haugen, B. J., Buckles, E. L., Lockatell, C. V., Johnson, D. E., Donnenberg, M. S., et al. (2004). Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72, 6373-6381. doi: 10.1128/IAI.72.11.6373-6381.2004
140. Sobel, J. D. (1985). New aspects of pathogenesis of lower urinary tract infections. Urology 26, 11-16.
141. Soler-García, A. A., Johnson, D., Hathout, Y., and Ray, P. E. (2009). Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases. Clin. J. Am. Soc. Nephrol. 4, 763-771. doi: 10.2215/CJN.0200608
142. Stamey, T. A., and Mihara, G. (1980). Observations on the growth of urethral and vaginal bacteria in sterile urine. J. Urol. 124, 461-463.
143. Storer, M. K., Hibbard-Melles, K., Davis, B., and Scotter, J. (2011). Detection of volatile compounds produced by microbial growth in urine by selected ion flow tube mass spectrometry (SIFT-MS). J. Microbiol. Methods 87, 111-113. doi: 10.1016/j.mimet.2011.06.012
144. Strøm, A. R., and Kaasen, I. (1993). Trehalose metabolism in Escherichia coli: stress protection and stress regulation of gene expression. Mol. Microbiol. 8, 205-210. doi: 10.1111/j.1365-2958.1993.tb01564.x
145. Styrvold, O. B., and Strøm, A. R. (1991). Synthesis, accumulation, and excretion of trehalose in osmotically stressed Escherichia coli K-12 strains: influence of amber suppressors and function of the periplasmic trehalase. J. Bacteriol. 173, 1187-1192.
146. Sundén, F., Håkansson, L., Ljunggren, E., and Wullt, B. (2006). Bacterial interference-is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int. J. Antimicrob. Agents 28(Suppl. 1), S26-S29. doi: 10.1016/j.ijantimicag.2006.05.007
147. Svanborg, C., Bergsten, G., Fischer, H., Godaly, G., Gustafsson, M., Karpman, D., et al. (2006). Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr. Opin. Microbiol. 9, 33-39. doi: 10.1016/j.mib.2005.12.012
148. Tan, C. K., Carey, A. J., Cui, X., Webb, R. I., Ipe, D., Crowley, M., et al. (2012). Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection. Infect. Immun. 80, 3145-3160. doi: 10.1128/IAI.00023-12
149. Tasevska, N., Runswick, S. A., McTaggart, A., and Bingham, S. A. (2005). Urinary sucrose and fructose as biomarkers for sugar consumption. Cancer Epidemiol. Biomarkers Prevent. 14, 1287-1294. doi: 10.1158/1055-9965.EPI-04-0827
150. Tielen, P., Rosin, N., Meyer, A. K., Dohnt, K., Haddad, I., Jänsch, L., et al. (2013). Regulatory and metabolic networks for the adaptation of Pseudomonas aeruginosa biofilms to urinary tract-like conditions. PLoS ONE 8:e71845. doi: 10.1371/journal.pone.0071845
151. Torffvit, O., and Agardh, C. D. (1993). Tubular secretion of Tamm-Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Nephron 65, 227-231. doi: 10.1159/000187479
152. Torzewska, A., Budzynska, A., Bialczak-Kokot, M., and Rózalski, A. (2014). In vitro studies of epithelium-associated crystallization caused by uropathogens during urinary calculi development. Microb. Pathog. 71-72, 25-31. doi: 10.1016/j.micpath.2014.04.007
153. Torzewska, A., and Rózalski, A. (2014). In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation. APMIS 122, 505-511. doi: 10.1111/apm.12191
154. Torzewska, A., and Rózalski, A. (2015). Various intensity of Proteus mirabilis-induced crystallization resulting from the changes in the mineral composition of urine. Acta Biochim. Pol. 62, 127-132. doi: 10.18388/abp.2014_882
155. Torzewska, A., Staczek, P., and Rózalski, A. (2003). Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides. J. Med. Microbiol. 52, 471-477. doi: 10.1099/jmm.0.05161-0
156. Ulett, G. C., Totsika, M., Schaale, K., Carey, A. J., Sweet, M. J., and Schembri, M. A. (2013). Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr. Opin. Microbiol. 16, 100-107. doi: 10.1016/j.mib.2013.01.005
157. Uppuluri, P., Dinakaran, H., Thomas, D. P., Chaturvedi, A. K., and Lopez-Ribot, J. L. (2009). Characteristics of Candida albicans biofilms grown in a synthetic urine medium. J. Clin. Microbiol. 47, 4078-4083. doi: 10.1128/JCM.01377-09
158. Vebø, H. C., Solheim, M., Snipen, L., Nes, I. F., and Brede, D. A. (2010). Comparative genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and their transcriptional responses to growth in human urine. PLoS ONE 5:e12489. doi: 10.1371/journal.pone.0012489
159. Vejborg, R. M., de Evgrafov, M. R., Phan, M. D., Totsika, M., Schembri, M. A., and Hancock, V. (2012). Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine. Infect. Immun. 80, 3179-3188. doi: 10.1128/IAI.00473-12
160. Watts, R. E., Hancock, V., Ong, C. L., Vejborg, R. M., Mabbett, A. N., Totsika, M., et al. (2010). Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. J. Clin. Microbiol. 48, 2449-2458. doi: 10.1128/JCM.01611-09
161. Watts, R. E., Tan, C. K., Ulett, G. C., Carey, A. J., Totsika, M., Idris, A., et al. (2012a). Escherichia coli 83972 expressing a P fimbriae oligosaccharide receptor mimic impairs adhesion of uropathogenic E. coli. J. Infect. Dis. 206, 1242-1249. doi: 10.1093/infdis/jis493
162. Watts, R. E., Totsika, M., Challinor, V. L., Mabbett, A. N., Ulett, G. C., De Voss, J. J., et al. (2012b). Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80, 333-344. doi: 10.1128/IAI.05594-11
163. Weinberg, E. D. (1978). Iron and infection. Microbiol. Rev. 42, 45-66.
164. Wenzler-Röttele, S., Dettenkofer, M., Schmidt-Eisenlohr, E., Gregersen, A., Schulte-Monting, J., and Tvede, M. (2006). Comparison in a laboratory model between the performance of a urinary closed system bag with double non-return valve and that of a single valve system. Infection 34, 214-218. doi: 10.1007/s15010-006-5626-2
165. Wernli, L., Bonkat, G., Gasser, T. C., Bachmann, A., and Braissant, O. (2013). Use of isothermal microcalorimetry to quantify the influence of glucose and antifungals on the growth of Candida albicans in urine. J. Appl. Microbiol. 115, 1186-1193. doi: 10.1111/jam.12306
166. Wilks, S. A., Fader, M. J., and Keevil, C. W. (2015). Novel insights into the Proteus mirabilis crystalline biofilm using real-time imaging. PLoS ONE 10:e0141711. doi: 10.1371/journal.pone.0141711
167. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603-D610. doi: 10.1093/nar/gkn810
168. Wullt, B. (2003). The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int. J. Antimicrob. Agents 21, 605-621. doi: 10.1016/S0924-8579(02)00328-X
169. Wullt, B., Connell, H., Röllano, P., Månsson, W., Colleen, S., and Svanborg, C. (1998). Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases. J. Urol. 159, 2057-2062. doi: 10.1016/S0022-5347(01)63246-4
170. Zdziarski, J., Brzuszkiewicz, E., Wullt, B., Liesegang, H., Biran, D., Voigt, B., et al. (2010). Host imprints on bacterial genomes-rapid, divergent evolution in individual patients. PLoS Pathog. 6:e1001078. doi: 10.1371/journal.ppat.1001078